AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/21/2024 | Press release | Distributed by Public on 05/20/2024 17:46
Please select the service you want to use:
Smartlinks | Seven West Media Limited | Seven Group Holdings Limited | Company News | Top Company News | Company Appointments | Arts and Culture | Entertainment | Media | Securities Issuers | Media Companies | Frankfurt Stock Exchange | Australian Securities Exchange (ASX) | Berlin Stock Exchange | Stuttgart Stock Exchange | OTC Markets | Tradegate Exchange | Chi-X Australia
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact